Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC(®) Natural Adjuvant against Aspergillosis

Invasive pulmonary aspergillosis represents one of the most serious fungal infections among immunocompromised patients. In this study, we aimed to analyze the in vivo efficacy of prophylactic oral amphotericin B (AMB) encapsulated in modified chitosan-nanoparticles (Nanomerics’ Molecular Envelope Te...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Cantero, Alba, Serrano, Dolores R., Navarro-Rodríguez, Patricia, Schätzlein, Andreas G., Uchegbu, Ijeoma F., Torrado, Juan J., Capilla, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781303/
https://www.ncbi.nlm.nih.gov/pubmed/31484389
http://dx.doi.org/10.3390/pharmaceutics11090456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781303/
https://www.ncbi.nlm.nih.gov/pubmed/31484389
http://dx.doi.org/10.3390/pharmaceutics11090456

Ejemplares similares